Clinical trial
A Multicentre Study of Subcutaneous Immunoglobulin (SCIG) in Patients With Multifocal Motor Neuropathy (MMN)
NCT00701662 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre Study of Subcutaneous Immunoglobulin (SCIG) in Patients With Multifocal Motor Neuropathy (MMN)
- Lead sponsor
- CSL Behring
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- January 31, 2009
- Enrollment
- 8 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
multifocal motor neuropathy (mmn)